Today: 9 April 2026
Subscribe
Browse Category

NYSE:HUM 27 January 2026 - 27 March 2026

UnitedHealth Stock Slides Again as April Earnings Loom, Putting UNH Valuation Under New Scrutiny

UnitedHealth Stock Slides Again as April Earnings Loom, Putting UNH Valuation Under New Scrutiny

UnitedHealth Group shares dropped over 4% Friday to $257.04, deepening losses after a 1.6% fall earlier in the week. Humana, Elevance, and Cigna also declined, while the Health Care Select Sector SPDR ETF slipped 1.5%. Analysts expect UnitedHealth’s first-quarter profit to fall 8.1% from last year, with investors focused on April 21 results for signs of easing medical costs.
27 March 2026
·····
UnitedHealth (UNH) stock price rises as markets slide — Medicare Advantage deadlines and Humana warning in focus

UnitedHealth (UNH) stock price rises as markets slide — Medicare Advantage deadlines and Humana warning in focus

UnitedHealth shares climbed nearly 2% to $284.37 Thursday, bucking a broad market selloff as investors focused on Medicare Advantage policy signals. Humana warned of a 2026 profit hit from lower Medicare Advantage “star” ratings, missing analyst expectations. All major U.S. indexes fell over 1%. Key Medicare rate decisions are due Feb. 25 and April 6.
12 February 2026
··
UnitedHealth stock price slips after hours as investors brace for early-April Medicare rate call

UnitedHealth stock price slips after hours as investors brace for early-April Medicare rate call

UnitedHealth shares slipped 0.3% to $275.70 in after-hours trading Monday, while the S&P 500 and Nasdaq closed higher. Healthcare stocks lagged as investors eyed Medicare Advantage reimbursement and cost trends ahead of key policy updates. Humana dropped 2.3%, CVS Health fell 3.3%, and Cigna rose 0.8%. UnitedHealth last month warned of its first revenue decline in decades if proposed Medicare rates hold.
10 February 2026
····
UnitedHealth stock heads into Monday after UNH’s 3% jump — what investors watch next

UnitedHealth stock heads into Monday after UNH’s 3% jump — what investors watch next

UnitedHealth shares rose 3% Friday to $276.65 after a volatile week for managed-care stocks. Investors await insurer earnings from CVS Health on Feb. 10 and Humana on Feb. 11 for updates on Medicare Advantage trends. The Centers for Medicare and Medicaid Services has proposed a 0.09% payment increase for 2027 plans. The comment period on the 2027 rate notice closes Feb. 25.
8 February 2026
···
UnitedHealth stock rebounds after hours as UNH recoups losses; Medicare rate debate looms

UnitedHealth stock rebounds after hours as UNH recoups losses; Medicare rate debate looms

UnitedHealth shares rose 3.4% to $277.57 Friday and gained another 3% after hours, rebounding after a volatile week for health insurers. Mizuho cut its price target on the stock to $350, citing delayed earnings recovery. Medicare Advantage rates and medical-cost trends remain key concerns. The Dow closed above 50,000, marking the strongest market gains in months.
7 February 2026
····
UnitedHealth stock falls again after FTC insulin deal puts OptumRx back in focus

UnitedHealth stock falls again after FTC insulin deal puts OptumRx back in focus

UnitedHealth shares fell nearly 3% to $275.92 in after-hours trading Wednesday after the FTC announced a 10-year insulin pricing settlement with Cigna’s Express Scripts, increasing scrutiny on OptumRx and CVS Caremark. Investors are watching for an FTC oral argument Feb. 5 and a House hearing on drug prices Feb. 11. CVS and Cigna shares also declined. UnitedHealth did not comment.
5 February 2026
·····
UnitedHealth stock bounces even after Truist, JPMorgan trim targets as Medicare Advantage rates loom

UnitedHealth stock bounces even after Truist, JPMorgan trim targets as Medicare Advantage rates loom

UnitedHealth shares rose 1% to $289.75 Monday, outperforming peers as Humana, Elevance, and Cigna declined. Truist and JPMorgan cut price targets but kept positive ratings. Investors focused on Medicare Advantage payment rates and 2026 cost trends after last week’s sector sell-off. Final 2027 Medicare Advantage rates are expected in April.
2 February 2026
·······
UnitedHealth stock slips after-hours as PBM fee disclosure rule adds fresh pressure on UNH

UnitedHealth stock slips after-hours as PBM fee disclosure rule adds fresh pressure on UNH

UnitedHealth shares fell 0.6% to $292.29 in after-hours trading Thursday after the U.S. Labor Department proposed new disclosure rules for pharmacy benefit managers. The proposal would require PBMs to reveal fee and compensation details. Investors are also closely watching upcoming Medicare Advantage rate decisions. Related health insurer stocks showed mixed movement late Thursday.
30 January 2026
·····
Elevance Health stock rises as ELV steadies after cautious 2026 outlook and Medicare rate jitters

Elevance Health stock rises as ELV steadies after cautious 2026 outlook and Medicare rate jitters

Elevance Health shares rose 1% to $345.44 Thursday, leading gains in managed-care stocks after policy and earnings volatility. The company forecast 2026 adjusted EPS of at least $25.50, below analyst expectations, and warned of revenue declines amid Medicaid and ACA headwinds. Medicare Advantage payments are set for a minimal 0.09% increase in 2027, rattling the sector. ACA enrollment for 2026 dropped to about 23 million as subsidies ended.
29 January 2026
·····
Dow Jones flattens near 49,000 as S&P 500 hits 7,000; Fed and Big Tech earnings loom

Dow Jones flattens near 49,000 as S&P 500 hits 7,000; Fed and Big Tech earnings loom

The Dow rose 49.62 points to 49,053.03 by midday Wednesday as the S&P 500 briefly topped 7,000 before retreating. Intel jumped 11.3%, while UnitedHealth plunged nearly 20% after the Trump administration proposed a 0.09% Medicare Advantage rate hike for 2027. The Fed is expected to hold rates steady. Seagate surged 19.3% on earnings.
28 January 2026
·······
Dow Jones today: Dow hovers near 49,000 as Fed decision and mega-cap earnings loom

Dow Jones today: Dow hovers near 49,000 as Fed decision and mega-cap earnings loom

The Dow Jones hovered near 49,000 Wednesday morning, dipping 3.56 points to 48,999.85 as UnitedHealth’s sharp fall continued to weigh on the index. The S&P 500 briefly topped 7,000, boosted by chip stocks after upbeat results from ASML and SK Hynix. The Federal Reserve’s policy decision is due at 2 p.m. EST. Meta, Microsoft, Tesla, and IBM report earnings after the bell.
28 January 2026
···········
Dow Jones today: Dow futures inch up as Fed decision and Big Tech earnings loom

Dow Jones today: Dow futures inch up as Fed decision and Big Tech earnings loom

Dow futures rose about 30 points ahead of the Fed’s policy decision, with S&P 500 and Nasdaq 100 futures also up. Health insurers slumped after U.S. officials proposed a 0.09% Medicare Advantage payment hike, far below expectations. The Dow fell 409 points Tuesday, dragged by UnitedHealth, Humana, and CVS losses, while the S&P 500 and Nasdaq hit records on tech gains. Microsoft and Meta will report earnings Wednesday.
28 January 2026
·····
Humana stock price tumbles 21% after Medicare Advantage rate proposal — what to watch next

Humana stock price tumbles 21% after Medicare Advantage rate proposal — what to watch next

Humana shares fell 21.1% to $207.93 in after-hours trading Tuesday after the Centers for Medicare & Medicaid Services proposed a 0.09% average payment increase for Medicare Advantage in 2027, far below analyst expectations. The draft also included stricter rules on diagnosis data. U.S. health insurer stocks dropped sharply, erasing billions in market value. Comments on the proposal are due by Feb. 25.
28 January 2026
··
UnitedHealth Group stock price tumbles: UNH slides nearly 20% after outlook, Medicare Advantage rates in focus

UnitedHealth Group stock price tumbles: UNH slides nearly 20% after outlook, Medicare Advantage rates in focus

UnitedHealth Group shares fell 19.5% to $282.90 in after-hours trading Tuesday after a weak Medicare Advantage rate proposal from the Trump administration. The company expects to lose up to 1.4 million Medicare Advantage members in 2026 and forecasts a drop in Medicaid membership. CVS and Humana shares also plunged. The government’s final Medicare Advantage rate decision is due April 6.
27 January 2026
···
1 2

Stock Market Today

  • CAVA Group (CAVA) Stock Sees Heavy Interest Amid Strong Earnings Outlook
    April 9, 2026, 10:52 AM EDT. Shares of CAVA Group, a Mediterranean restaurant chain, have gained 8.9% in the past month, outperforming the Zacks S&P 500 composite and its restaurant industry peers. Analysts forecast significant earnings growth, with Q1 EPS expected to rise 83.3% year-over-year to $0.11 and full-year EPS estimates up over 100%. The Zacks Rank system has assigned CAVA a #1 (Strong Buy) rating due to positive revisions in earnings projections. Revenue growth remains critical for sustaining earnings momentum. Investors are closely watching these fundamental factors amid heightened stock search interest on Zacks.com.

Latest article

SoFi Technologies Stock Slips as Wall Street Cuts Targets Ahead of Q1 Earnings

SoFi Technologies Stock Slips as Wall Street Cuts Targets Ahead of Q1 Earnings

9 April 2026
SoFi Technologies shares fell 1.9% to $16.18 Thursday after KBW and Wells Fargo cut price targets ahead of first-quarter results due April 29. The moves follow Muddy Waters’ short position and claims of accounting issues, which SoFi denies. Affirm and LendingClub also traded lower. Barclays and other banks have trimmed targets as concerns mount over credit quality and sector valuations.
Tesla revives cheaper EV bet with compact SUV plan in China after sales strain

Tesla revives cheaper EV bet with compact SUV plan in China after sales strain

9 April 2026
Tesla is developing a smaller, cheaper electric SUV to be built first in Shanghai, sources said. The new model would cost less than the Model 3 and be smaller than the Model Y. Tesla produced 408,386 vehicles but delivered only 358,023 in Q1, as U.S. demand weakened and competition increased. Shares fell 0.8% Thursday.
Grab Holdings Bets on AI as Group Ride Tool Targets 40% Lower Fares

Grab Holdings Bets on AI as Group Ride Tool Targets 40% Lower Fares

9 April 2026
Grab Holdings launched 13 new AI-powered products in Jakarta, including a “Group Ride” feature that can cut fares by up to 40% for shared routes. CEO Anthony Tan said the tools aim to offset rising fuel costs and support demand as households tighten spending. The company’s 2026 revenue and profit forecasts remain below analyst expectations. Grab’s $600 million deal to buy Foodpanda Taiwan is pending regulatory approval.
Nokia Oyj AI Data Center Push Gets Lift From Fifth Straight GigaOm Leader Ranking

Nokia Oyj AI Data Center Push Gets Lift From Fifth Straight GigaOm Leader Ranking

9 April 2026
Nokia was named a Leader and Outperformer in GigaOm’s 2026 Radar for data center switching for the fifth year in a row, competing with Cisco, Arista, and HPE Juniper. Shares fell 1.05% in Helsinki ahead of Thursday’s annual meeting, where board changes and a dividend of up to 14 euro cents per share will be considered.
American Airlines Faces FAA Fine Over Drug-Testing Lapses in New Test for 2026 Turnaround

American Airlines Faces FAA Fine Over Drug-Testing Lapses in New Test for 2026 Turnaround

9 April 2026
The FAA proposed a $255,000 civil penalty against American Airlines, alleging the carrier allowed 12 flight attendants who tested positive for drugs or alcohol to return to safety-sensitive duties before completing required follow-up tests. The alleged violations occurred from May 2019 to December 2023. American has 30 days to respond. The airline said it is reviewing the notice.
Go toTop